Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Lung Cancer Management|August 20, 2013
Targeted therapy for squamous cell lung cancerRachel G Liao, Hideo Watanabe, Matthew Meyerson, et al.The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|April 18, 2019
BRCA1/2 Variant Data-Sharing PracticesJuli M Bollinger, Abhi Sanka, Lena Dolman, et al.Cancer Research|July 19, 2014
Kinase domain activation of FGFR2 yields high-grade lung adenocarcinoma sensitive to a Pan-FGFR inhibitor in a mouse model of NSCLCJeremy H Tchaicha, Esra A Akbay, Abigail Altabef, et al.Cancer Research|June 22, 2013
Inhibitor-sensitive FGFR2 and FGFR3 mutations in lung squamous cell carcinomaRachel G Liao, Joonil Jung, Jeremy Tchaicha, et al.Molecular Cancer Therapeutics|April 15, 2018
RAS-MAPK Reactivation Facilitates Acquired Resistance in <i>FGFR1</i>-Amplified Lung Cancer and Underlies a Rationale for Upfront FGFR-MEK BlockadeBruno Bockorny, Maria Rusan, Wankun Chen, et al.Proceedings of the National Academy of Sciences of the United States of America|October 29, 2014
Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitorsLi Tan, Jun Wang, Junko Tanizaki, et al.Nature Medicine|May 6, 2016
Facilitating a culture of responsible and effective sharing of cancer genome dataLillian L Siu, Mark Lawler, David Haussler, et al.Plos Genetics|December 27, 2018
BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2Melissa S Cline, Rachel G Liao, Michael T Parsons, et al.Diabetes|August 26, 2017
A Loss-of-Function Splice Acceptor Variant in <i>IGF2</i> Is Protective for Type 2 DiabetesJosep M Mercader, Rachel G Liao, Avery D Bell, et al.Pageof 1